Quest Diagnostics Inc (NYSE:DGX)
$ 153.02 0 (0%) Market Cap: 17.08 Bil Enterprise Value: 23.40 Bil PE Ratio: 20.57 PB Ratio: 2.52 GF Score: 86/100

Quest Diagnostics Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 11:45PM GMT
Release Date Price: $142.11 (+0.36%)
Lisa Christine Gill
JPMorgan Chase & Co, Research Division - Analyst

Good afternoon. My name is Lisa Gill, and I am Head of Health Care Services at JPMorgan. It is with great pleasure that I have with me Quest Diagnostics this afternoon. For those of you that have followed our research, you may know that I followed the lab industry from 2011 to 2021. And then in 2021, I gave it to our life sciences analyst. So when I had the opportunity a couple of months ago to take it back, it was a great opportunity. So one, I'm super happy to have you here.

Second, this is my first time with this management team. So the management team changed over in that 2-year period of time. To my left is CEO, Jim Davis, and to his left is Sam Samad. And as just a funny background, Sam came from Cardinal Health, and we just reconnected in the fact that I think we met probably 15 years ago.

Sam A. Samad;Lisa Christine Gill
Quest Diagnostics Incorporated - Executive VP & CFO;JPMorgan Chase & Co,

Yes, probably something like that.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot